Past obesity as well as present body weight status is a risk factor for diabetic nephropathy

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Meguro, Shu ^a,b   Kabeya, Yusuke ^b   Tanaka, Karin ^a   Kawai, Toshihide ^a   Tomita, Masuomi ^b   Katsuki, Takeshi ^b   Oikawa, Yoichi ^b   Atsumi, Yoshihito ^b,c   Shimada, Akira ^b   Tanaka, Masami ^a   Irie, Junichiro ^a   Saisho, Yoshifumi ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c Life Extension Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; LEAN BODY WEIGHT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 84884231253     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/590569     Document Type: Article

References (24)

1. Kosaka K., Ogata Y., Obesity and diabetes mellitus Saishin Igaku 1961 16 10 2602 2608
2. Sone H., Yoshimura Y., Ito H., Ohashi Y., Yamada N., Energy intake and obesity in Japanese patients with type 2 diabetes. The Lancet 2004 363 9404 248 249 2-s2.0-1642493730 10.1016/S0140-6736(03)15348-2
3. Park J. Y., Lee K., Kim C. H., Kim H. K., Hong S. K., Park K. S., Lee H. K., Min H. K., Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 1997 35 1 49 56 2-s2.0-0031080351 10.1016/S0168-8227(96)01363-0
4. Nishimura T., Nakajima K., Kusuoka H., Yamashina A., Nishimura S., Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 2 319 328 2-s2.0-38349092238 10.1007/s00259-007-0608-x
5. Haffner M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The New England Journal of Medicine 1998 339 4 229 234
6. Sone H., Tanaka S., Iimuro S., Tanaka S., Oida K., Yamasaki Y., Oikawa S., Ishibashi S., Katayama S., Yamashita H., Ito H., Yoshimura Y., Ohashi Y., Akanuma Y., Yamada N., Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 2010 53 3 419 428 2-s2.0-77949266532 10.1007/s00125-009-1622-2
7. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6
8. Holman R. R., Paul S. K., Bethel M. A., Matthews D. R., Neil H. A. W., 10-year follow-up of intensive glucose control in type 2 diabetes. The New England Journal of Medicine 2008 359 15 1577 1589 2-s2.0-53749096863 10.1056/NEJMoa0806470
9. Gall M., Hougaard P., Borch-Johnsen K., Parving H., Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. British Medical Journal 1997 314 7083 783 788 2-s2.0-0030934033
10. Ravid M., Brosh D., Ravid-Safran D., Levy Z., Rachmani R., Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Archives of Internal Medicine 1998 158 9 998 1004 2-s2.0-0032507776 10.1001/archinte.158.9.998
11. Retnakaran R., Cull C. A., Thorne K. I., Adler A. I., Holman R. R., Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 2006 55 6 1823 1939 2-s2.0-79959400407 10.2337/db11-er06
12. Ogawa K., Ueda K., Sasaki H., Yamasaki H., Okamoto K., Wakasaki H., Matsumoto E., Furuta H., Hanabusa T., Nishi M., Nanjo K., History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy. Diabetes Research and Clinical Practice 2004 66 supplement 1 S165 S168 2-s2.0-9644303311 10.1016/j.diabres.2003.09.020
13. Kadowaki T., Miyake Y., Hagura R., Kajinuma H., Kuzuya N., Akanuma Y., Kosaka K., On the pathogenesis of type II diabetes with special reference to diminished insulin response and obesity: a 5-12 year follow-up study of subjects with borderline glucose tolerance. Tohoku Journal of Experimental Medicine 1983 141 141 146 2-s2.0-0021002736
14. Examination Committee of Criteria for "Obesity Disease" in Japan, Japan Society for the Study of Obesity, New criteria for "obesity disease" in Japan. Circulation 2002 66 11 987 992 2-s2.0-33644829600
15. Kashiwagi A., Kasuga M., Araki E., Oka Y., Hanafusa T., Ito H., Tominaga M., Oikawa S., Noda M., Kawamura T., Sanke T., Namba M., Hashiramoto M., Sasahara T., Nishio Y., Kuwa K., Ueki K., Takei I., Umemoto M., Murakami M., Yamakado M., Yatomi Y., Ohashi H., International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation 2012 3 1 8 10 2-s2.0-84857217561
16. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., Revised equations estimated GFR from serum creatinine. American Journal of Kidney Diseases 2009 53 6 982 992 2-s2.0-65549111017 10.1053/j.ajkd.2008.12.034
17. Davis D., Kern T., Rand L. I., Alberti K. G. M. M., Zimmet P., DeFronzo R. A., Diabetic retinopathy. International Textbook of Diabetes Mellitus 1997 2nd Chichester, UK John Wiley & Sons 1413 1446
18. Ninomiya T., Perkovic V., de Galan B. E., Zoungas S., Pillai A., Jardine M., Patel A., Cass A., Neal B., Poulter N., Mogensen C., Cooper M., Marre M., Williams B., Hamet P., Mancia G., Woodward M., MacMahon S., Chalmers J., Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Journal of the American Society of Nephrology 2009 20 8 1813 1821 2-s2.0-68149170224 10.1681/ASN.2008121270
19. Meguro S., Shigihara T., Kabeya Y., Tomita M., Atsumi Y., Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects. Internal Medicine 2009 48 9 657 663 2-s2.0-67650034212 10.2169/internalmedicine.48.1865
20. Hoefield R. A., Kalra P. A., Baker P. G., Sousa I., Diggle P. J., Gibson M. J., O'Donoghue D. J., Middleton R. J., New J. P., The use of eGFR and ACR to predict decline in renal function in people with diabetes. Nephrology Dialysis Transplantation 2011 26 3 887 892 2-s2.0-79952144513 10.1093/ndt/gfq526
21. Yokoyama H., Kanno S., Takahashi S., Yamada D., Honjo J., Saito K., Sone H., Haneda M., Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes. Nephrology Dialysis Transplantation 2011 26 9 2924 2930 2-s2.0-80053219522 10.1093/ndt/gfq774
22. Meguro S., Tomita M., Kabeya Y., Factors associated with the decline of kidney function differ among eGFR strata in subjects with type 2 diabetes mellitus. International Journal of Endocrinology 2012 2012 6 687867 10.1155/2012/687867
23. Ross W. R., McGill J. B., Epidemiology of obesity and chronic kidney disease. Advances in Chronic Kidney Disease 2006 13 4 325 335 2-s2.0-33749424934 10.1053/j.ackd.2006.07.012
24. Vivante A., Golan E., Tzur D., Leiba A., Tirosh A., Skorecki K., Calderon-Margalit R., Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Archives of Internal Medicine 2012 172 21 1644 1650